Transcardiac extraction of circulating endothelin-1 across the failing heart

T Tsutamoto1, A Wada, K Maeda

  • 1First Department of Internal Medicine, Shiga University of Medical Science, Seta, Otsu, Japan. tutamoto@belle.shiga-med.ac.jp

Insights

In congestive heart failure (CHF), the failing heart extracts endothelin-1 (ET-1). This extraction correlates with left ventricular remodeling, suggesting ET-1 receptor upregulation in severe CHF.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Biochemistry

Background:

  • Congestive heart failure (CHF) involves complex cardiovascular changes.
  • Endothelin-1 (ET-1) is a potent vasoconstrictor implicated in heart disease.
  • Understanding ET-1's role in the failing heart is crucial for therapeutic development.

Purpose of the Study:

  • To investigate the transcardiac gradient of plasma endothelin-1 (ET-1) in patients with congestive heart failure (CHF).
  • To determine the relationship between ET-1 gradient and indicators of cardiac dysfunction and remodeling.

Main Methods:

  • Plasma ET-1 levels were measured in the aortic root and coronary sinus of normal subjects and CHF patients.
  • Transcardiac ET-1 gradient was calculated and correlated with clinical parameters.
  • Statistical analyses, including stepwise multivariate analysis, were performed.

Main Results:

  • Normal subjects and mild CHF patients showed ET-1 spillover into the coronary sinus.
  • Severe CHF patients exhibited significant ET-1 extraction across the heart.
  • The transcardiac ET-1 gradient correlated with left ventricular end-diastolic volume index and myocardial fibrosis markers.

Conclusions:

  • Elevated circulating ET-1 is extracted by the failing heart in severe CHF.
  • The transcardiac ET-1 gradient is independently associated with left ventricular remodeling.
  • Upregulated ET-1 receptors in the failing ventricle may mediate ET-1's role in left ventricular remodeling.